DataMeds AI Regains Nasdaq Equity Compliance
DataMeds AI said it regained compliance with Nasdaq Listing Rule 5550(b)(1) after stockholders’ equity exceeded $2.5 million.
DataMeds AI regained compliance with Nasdaq Listing Rule 5550(b)(1) after its stockholders' equity exceeded $2.5 million.Key Highlights:Original SEC Filing: DataMeds AI, Inc. [ MEDS ] - 8-K - Oct. 20, 2026This is an AI-powered summary. It may contain inaccuracies.
Consider verifying important infor…